Privi Speciality Chemicals Limited has informed the Exchange regarding Board meeting held on May 03, 2025.
PRIVISCL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The board approved audited standalone and consolidated financial results for Q4 and full year ended March 31, 2025, with an unmodified (clean) opinion from statutory auditors BSR & Co. LLP. On a standalone basis, FY25 revenue from operations grew to Rs. 2,03,834 lakhs (up from Rs. 1,73,368 lakhs in FY24), while net profit nearly doubled to Rs. 18,853 lakhs versus Rs. 9,500 lakhs in FY24. The board recommended a final dividend of Rs. 5 per share (50%) on a face value of Rs. 10, totaling about Rs. 1,953 lakhs, subject to shareholder approval at the 40th AGM on August 1, 2025 (record date: July 24, 2025). BSR & Co. LLP was re-appointed as statutory auditors for a second 5-year term, and Rathi & Associates was appointed as secretarial auditor for a 5-year term starting FY26.
Strong results with nearly 98% jump in annual net profit and healthy dividend payout are positive for shareholders, signaling robust earnings momentum. The clean audit opinion and continuity of the statutory auditor provide comfort on governance and reporting quality, likely to be viewed favorably by the market.